Weber, Thomas

Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy

Louis Jeune, V., Joergensen, J. A., Hajjar, R. J., & Weber, T. (2013) · Human Gene Therapy Methods

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 358

Intracellular transport of recombinant adeno-associated virus vectors

Nonnenmacher, M., & Weber, T. (2012) · Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 258

Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models

Rapti, K., Louis-Jeune, V., Kohlbrenner, E., Ishikawa, K., Ladage, D., Zolotukhin, S., Hajjar, R. J., & Weber, T. (2012) · Molecular Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 170

Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids

Chamberlain, K., Riyad, J. M., & Weber, T. (2016) · Human Gene Therapy Methods

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 141

Successful transduction with AAV vectors after selective depletion of anti-AAV antibodies by immunoadsorption

Orlowski, A., Katz, M. G., Gubara, S. M., Fargnoli, A. S., Fish, K. M., & Weber, T. (2020) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 74

Effect of bortezomib on the efficacy of AAV9. SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure

Chaanine, A. H., Nonnenmacher, M., Kohlbrenner, E., Jin, D., Kovacic, J. C., Akar, F. G., Hajjar, R. J., & Weber, T. (2014) · Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 25